HealthCare Global Enterprises (NSE:HCG) Cyclically Adjusted PB Ratio: 9.20 (As of Jul. 31, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
82 GF Score
Price ₹671.20
GF Value ₹583.34
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Cyclically Adjusted PB Ratio?

HealthCare Global Enterprises NSE:HCG +0.23% 82 Cyclically Adjusted PB Ratio is 9.20 as of Jul. 31, 2026, which is 6% above its 10-year median of 8.65. GuruFocus rates NSE:HCG with a GF Score™ of 82/100 and a GF Value™ of ₹583.34 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 356 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks worse than 92.13% on this metric.

As of today (2026-07-31), HealthCare Global Enterprises's current share price is ₹671.20. HealthCare Global Enterprises's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹72.92. HealthCare Global Enterprises's Cyclically Adjusted PB Ratio for today is 9.20.

The historical rank and industry rank for HealthCare Global Enterprises's Cyclically Adjusted PB Ratio or its related term are showing as below:

NSE:HCG' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7.24   Med: 8.65   Max: 10.55
Current: 9.14

During the past years, HealthCare Global Enterprises's highest Cyclically Adjusted PB Ratio was 10.55. The lowest was 7.24. And the median was 8.65.

NSE:HCG's Cyclically Adjusted PB Ratio is ranked worse than
92.13% of 356 companies
in the Healthcare Providers & Services industry
Industry Median: 1.84 vs NSE:HCG: 9.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

HealthCare Global Enterprises's adjusted book value per share data for the three months ended in Mar. 2026 was ₹89.213. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹72.92 for the trailing ten years ended in Mar. 2026.

Shiller PE for Stocks: The True Measure of Stock Valuation


HealthCare Global Enterprises  (NSE:HCG) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


HealthCare Global Enterprises Cyclically Adjusted PB Ratio Related Terms


HealthCare Global Enterprises Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises Cyclically Adjusted PB Ratio Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 7.72 7.20

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.72 0.00 8.93 0.00 7.20

NSE:HCG vs HCA, THC, DVA: Cyclically Adjusted PB Ratio Comparison

For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthCare Global Enterprises Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where HealthCare Global Enterprises's Cyclically Adjusted PB Ratio falls into.


NSE:HCG
82GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

HealthCare Global Enterprises's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=671.20/72.92
=9.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, HealthCare Global Enterprises's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=89.213/164.2724*164.2724
=89.213

Current CPI (Mar. 2026) = 164.2724.

HealthCare Global Enterprises Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 105.961 0.000
201609 52.946 105.961 82.083
201612 0.000 105.196 0.000
201703 50.168 105.196 78.342
201706 0.000 107.109 0.000
201709 49.852 109.021 75.117
201712 0.000 109.404 0.000
201803 58.908 109.786 88.144
201806 0.000 111.317 0.000
201809 54.429 115.142 77.654
201812 0.000 115.142 0.000
201903 53.882 118.202 74.883
201906 0.000 120.880 0.000
201909 51.279 123.175 68.388
201912 0.000 126.235 0.000
202003 42.723 124.705 56.278
202006 0.000 127.000 0.000
202009 64.857 130.118 81.881
202012 0.000 130.889 0.000
202103 55.273 131.771 68.906
202106 0.000 134.084 0.000
202109 62.704 135.847 75.825
202112 0.000 138.161 0.000
202203 62.221 138.822 73.628
202206 0.000 142.347 0.000
202209 62.958 144.661 71.493
202212 0.000 145.763 0.000
202303 61.476 146.865 68.763
202306 0.000 150.280 0.000
202309 61.219 151.492 66.384
202312 0.000 152.924 0.000
202403 58.921 153.035 63.248
202406 0.000 155.789 0.000
202409 61.448 157.882 63.935
202412 0.000 158.323 0.000
202503 65.759 157.552 68.564
202506 0.000 159.755 0.000
202509 64.891 162.289 65.684
202512 0.000 163.281 0.000
202603 89.213 164.272 89.213

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PB Ratio of 9.20 mean?
HealthCare Global Enterprises (NSE:HCG) has a Cyclically Adjusted PB Ratio of 9.20 as of Jul. 31, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on HealthCare Global Enterprises and its competitors. This is near median its historical median of 8.65. Over the past decade, HealthCare Global Enterprises' Cyclically Adjusted PB Ratio has ranged from 7.24 to 10.55. According to the industry distribution chart, HealthCare Global Enterprises ranks #328 out of 356 companies in the Healthcare Providers & Services industry, placing it in the top 92.1%.
Is HealthCare Global Enterprises' Cyclically Adjusted PB Ratio too high?
HealthCare Global Enterprises' current Cyclically Adjusted PB Ratio of 9.20 is near median its 10-year median of 8.65. Over the past 10 years, this metric has ranged from a low of 7.24 to a high of 10.55. The Healthcare Providers & Services industry median Cyclically Adjusted PB Ratio is 1.84. HealthCare Global Enterprises' value of 9.20 is 400% above this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #328 out of 356 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HealthCare Global Enterprises has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Cyclically Adjusted PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #328 out of 356 companies for Cyclically Adjusted PB Ratio. This places HealthCare Global Enterprises in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.84. HealthCare Global Enterprises' value of 9.20 is 400% above this benchmark. Historically, HealthCare Global Enterprises' own Cyclically Adjusted PB Ratio has ranged from 7.24 to 10.55 over the past decade. While the company's 10-year median is 8.65 vs. the industry median of 1.84, HealthCare Global Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PB Ratio among Healthcare Providers & Services companies is 1.84, based on 356 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current Cyclically Adjusted PB Ratio of 9.20 is 400% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PB Ratio is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current Cyclically Adjusted PB Ratio is 9.20, which is near median its own 10-year median of 8.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹583.34, compared to a current price of ₹671.20 — trading 15.1% above its estimated fair value. The current Cyclically Adjusted PB Ratio is 9.20, which is near median its 10-year median of 8.65 and 400% above the Healthcare Providers & Services industry median of 1.84. HealthCare Global Enterprises' overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Cyclically Adjusted PB Ratio is 9.20 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹671.20 is trading 15.1% above its estimated GF Value™ of ₹583.34. GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.

Key valuation signals for NSE:HCG:

  • Cyclically Adjusted PB Ratio: 9.20 (near median its 10-year median of 8.65)
  • GF Value™: ₹583.34 vs. price of ₹671.20 (15.1% above fair value)
  • GF Score™: 82/100 with 2 warning signs
  • Industry Position: 400% above the Healthcare Providers & Services median (#328 of 356)

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
82GF Score

Get the complete analysis for NSE:HCG

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹671.20
Price
₹583.34
GF Value